Patients with a dysfunctional aortic heart valve who received a new, prosthetic valve through a minimally invasive procedure had similar outcomes at five years as those who underwent open-heart surgery, a new study shows.
Show moreResearchers from the National Institute for Health and Care Research (NIHR) Manchester Biomedical Research Center (BRC) and University of Manchester have been instrumental in developing the first guideline for cancer screening in an inflammatory muscle disease called "myositis," which has an increased cancer risk.
Show moreNew research by RCSI University of Medicine and Health Sciences published in the Blood Journal has revealed that the age at which individuals are tested for von Willebrand disease (VWD), a common bleeding disorder, significantly affects their diagnosis.
Show moreFindings from the largest study to date in Ireland to characterise the population affected by chronic kidney disease (CKD), over the age of 50 years, have been published.
Show moreA new study from RCSI's School of Population Health has found that future developments to Irish stroke services, according to those who are most impacted, must prioritise specialist community-based rehabilitation, ongoing support for life after stroke and better information and support for navigating services.
Show moreWhat if just observing Artificial Intelligence (AI) could make a clinician more efficient at their job and improve care outcomes for patients?
Show moreAn international research team led by Krembil Brain Institute Neurologist and Senior Scientist, Dr. Anthony Lang, has proposed a new model for classifying Parkinson's disease (PD).
Show moreScientists at the University of Galway in Ireland and MIT have collaborated to create a soft robotic implant that can work to fight fibrotic encapsulation and deliver drugs despite the presence of fibrous scar tissue. The device, which the researchers have termed the FibroSensing Dynamic Soft Reservoir (FSDSR), is designed to reside in the body for extended periods and deliver drugs.
Show moreResearchers have discovered the link between the gut microbiota and Alzheimer's disease. For the first time, researchers have found that Alzheimer's symptoms can be transferred to a healthy young organism via the gut microbiota, confirming its role in the disease.
Show moreResearchers at the University of Michigan have developed a model for studying one type of familial epilepsy, opening the door to understanding—and eventually targeting—the mechanisms that lead to the disorder and its associated fatalities.
Show moreAsk Speakers
Medical Information Request
Reporting of side effects
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk profile of the medicinal product. All suspected adverse reactions should be reported to HPRA Pharmacovigilance, website www.hpra.ie. Adverse events can also be reported to Novartis preferably at www.novartis.com/report, by emailing [email protected] or by calling (01) 2080 612.